Choose your preferred way to stay informed of new case launches and settlement deadlines
On July 5, 2023, after the market closed, Waldencast filed a current report with the U.S. Securities and Exchange Commission in which it disclosed, among other things that certain financial statements of Obagi, a skin care company that Waldencast had acquired, could no longer be relied upon because Waldencast expected to restate those financial statements. On this news, the price of Waldencast stock fell over 10%, closing at $6.63 on July 6, 2023.
In order to be eligible to join the WALD class action lawsuit, you must have incurred a loss on shares of Waldencast purchased during the class period listed above.
TOP
